Addex Therapeutics Ltd (ADXN)

Addex Therapeutics Revenue

Addex Therapeutics had revenue of $1.57M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $266.94K. In the year 2023, Addex Therapeutics had annual revenue of $1.96M with 26.20% growth.

• Revenue (ttm): $1.57M
• Revenue Growth: -16.21%
• P/S Ratio: 8.40
• Revenue / Employee: $68,178
• Employees: 23
• Market Cap: 13.17M USD

Revenue Chart

* The company reports in CHF currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.96M	407.08K	26.20%
Dec 31, 2022	1.55M	-1.91M	-55.16%
Dec 31, 2021	3.47M	-942.95K	-21.39%
Dec 31, 2020	4.41M	1.49M	50.90%
Dec 31, 2019	2.92M	-3.92M	-57.29%
Dec 31, 2018	6.84M	6.33M	1,233.43%
Dec 31, 2017	512.92K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.